Posts By Alex
571Wire StoriesCanva Introduces Student-Safe AI Products, Customizable Lessons for Teachers, and Over 5,000 Free Classroom Resources to 50 Million Students and Teachers
Releases AI in Education Report, revealing 93% don’t know where to start with AI Unveils the world’s first range of safe and...
- 491Wire Stories
ImmuneOncia Announces Phase 1 Results of CD47 Antibody at ESMO 2023
SEOUL, South Korea–(BUSINESS WIRE)–ImmuneOncia (CEO Heung Tae Kim) announced the results of its Phase 1a solid tumour clinical trial (IMC-002-K102 Study) of...
- 441Wire Stories
Eli Israeli Joins Odysight.ai as Chief Technology Officer
OMER, Israel, Oct. 23, 2023 (GLOBE NEWSWIRE) — Odysight.ai Inc. (OTCQB: SCTC), a leading provider of visual based predictive maintenance (PdM) and...
- 407Wire Stories
Nighthawk Gold Delivers Inaugural ESG Report
TORONTO–(BUSINESS WIRE)–$MIMZF #esg—Nighthawk Gold Corp. (“Nighthawk†or the “Companyâ€) (TSX: NHK; OTCQX: MIMZF) delivers its Inaugural Environmental, Social, and Governance (“ESGâ€) Report,...
- 495Wire Stories
Alipay+ partners LankaPay to enhance digital travel experience to and from Sri Lanka
More than 400,000 merchants in Sri Lanka will be able to accept cross-border digital payments from some of Asia’s most popular digital...
- 477Wire Stories
SkyDrive Selected for Innovation Grant Worth up to 12.4 Billion Yen by Japanese Government
TOYOTA, Japan–(BUSINESS WIRE)–#FlyingCars–SkyDrive Inc. (“SkyDriveâ€), a leading Japanese eVTOL aircraft (*1) manufacturer based in Japan, is pleased to announce that it has...
- 429Wire Stories
Fearless, Solid and Reliable, DONGFENG KC Ushers a New Journey in the World
WUHAN, China–(BUSINESS WIRE)–Customer-oriented, in response to the dominance of road transport in many regions around the world, Dongfeng Commercial Vehicles launched new...
- 401Wire Stories
HighField Biopharmaceuticals Announces Positive Phase 1a Data of HF1K16, a new Immuno-Oncology Drug, For Patients with Recurrent and Refractory Glioma
HighField CEO Yuhong Xu and CBO Donald Wyatt are attending BIO-Europe, November 6 – 8, 2023 to discuss these significant early results...
- 503Wire Stories
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
First market approval for Genexine discovered and developed therapeutic drug, Efesa (Efepoetin alfa), a long-acting erythropoietin (EPO) for the treatment of Chronic...
- 462Wire Stories
National Football League Teams Up with SES for Game Content Distribution
In a renewed partnership, SES’s hybrid distribution network to enable the NFL to reach over 35 partners in Europe, Asia and the...
